Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Kramer

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|April 9, 2026
Prognostication of Liver Disease Patients via the WFUMB 'Rule-of-4' Algorithm Using SSI-2D-SWE-Based Liver Stiffness MeasurementChristian Sebesta, Georg Kramer, Nina Dominik, et al.
The American Journal of Gastroenterology|April 22, 2026
Sex does not impact the performance of non-invasive tests for clinically significant portal hypertension in cACLDPaula Höfinger, Helena Schluchter, Georg Semmler, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2025
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and DeathMathias Jachs, Tânia Carvalho, Benedikt Simbrunner, et al.
Alimentary Pharmacology & Therapeutics|January 23, 2026
The Alpha-1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLDLorenz Balcar, Georg Semmler, Bernhard Scheiner, et al.
Alimentary Pharmacology & Therapeutics|July 28, 2025
Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non-Acute DecompensationLucie Simonis, Lorenz Balcar, Anna Schedlbauer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 7, 2025
Non-Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1-Negative Myeloproliferative NeoplasmsLorenz Balcar, Lina Degenfeld-Schonburg, Can Hopp, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2025
Diagnostic and Clinical Implications of High Spleen-To-Liver Stiffness Ratio in MASH-A Prospective, Comparative StudyChristian Sebesta, Mathias Jachs, Lukas Hartl, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2025
Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver DiseaseBenedikt Simbrunner, Ida Falk Villesen, Georg Semmler, et al.
JHEP Reports : Innovation in Hepatology|March 5, 2026
Non-invasive tests to guide hepatocellular carcinoma surveillanceJan Embacher, Katharina Remih, Carolin Victoria Schneider, et al.
Hepatology International|April 15, 2026
Impact of pharmacological sGC stimulation with Riociguat in experimental models of liver disease regressionKatharina Bonitz, Philipp Königshofer, Henriette Horstmeier, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Liver International : Official Journal of the International Association for the Study of the Liver|April 9, 2026
Prognostication of Liver Disease Patients via the WFUMB 'Rule-of-4' Algorithm Using SSI-2D-SWE-Based Liver Stiffness MeasurementChristian Sebesta, Georg Kramer, Nina Dominik, et al.
The American Journal of Gastroenterology|April 22, 2026
Sex does not impact the performance of non-invasive tests for clinically significant portal hypertension in cACLDPaula Höfinger, Helena Schluchter, Georg Semmler, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2025
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and DeathMathias Jachs, Tânia Carvalho, Benedikt Simbrunner, et al.
Alimentary Pharmacology & Therapeutics|January 23, 2026
The Alpha-1 Pi*MZ Genotype Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Patients With ACLDLorenz Balcar, Georg Semmler, Bernhard Scheiner, et al.
Alimentary Pharmacology & Therapeutics|July 28, 2025
Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non-Acute DecompensationLucie Simonis, Lorenz Balcar, Anna Schedlbauer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 7, 2025
Non-Invasive Stratification of Portal Hypertension in Patients With BCR::ABL1-Negative Myeloproliferative NeoplasmsLorenz Balcar, Lina Degenfeld-Schonburg, Can Hopp, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 30, 2025
Diagnostic and Clinical Implications of High Spleen-To-Liver Stiffness Ratio in MASH-A Prospective, Comparative StudyChristian Sebesta, Mathias Jachs, Lukas Hartl, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2025
Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver DiseaseBenedikt Simbrunner, Ida Falk Villesen, Georg Semmler, et al.
JHEP Reports : Innovation in Hepatology|March 5, 2026
Non-invasive tests to guide hepatocellular carcinoma surveillanceJan Embacher, Katharina Remih, Carolin Victoria Schneider, et al.
Hepatology International|April 15, 2026
Impact of pharmacological sGC stimulation with Riociguat in experimental models of liver disease regressionKatharina Bonitz, Philipp Königshofer, Henriette Horstmeier, et al.
Pageof 3